To establish a deficit-neutral reserve fund to support investments in precision medicine, biomedical research, and the National Institutes of Health.

SA 1099. Mr. MORAN (for himself, Mrs. Murray, Mr. Alexander, Mr. Durbin, Mr. Graham, Mr. Markey, Ms. Collins, Mr. Coons, Mr. Johnson, Mr. Wicker, Mr. Casey, Mr. Burr, Mr. Brown, Mr. Isakson, Mr. Schumer, Mr. Roberts, Ms. Klobuchar, Mr. Cassidy, Mr. Peters, Mr. Kirk, Ms. Hirono, Ms. Ayotte, Mr. Reed, Mr. Toomey, Mr. Franken, Mr. Hatch, Mr. Whitehouse, Mr. Gardner, Ms. Cantwell, Mr. Blunt, Mr. Booker, Mr. King, Mr. Merkley, Ms. Baldwin, and Mr. Blumenthal) proposed an amendment to the concurrent resolution S. Con. Res. 11, setting forth the congressional budget for the United States Government for fiscal year 2016 and setting forth the appropriate budgetary levels for fiscal years 2017 through 2025; as follows:

At the appropriate place, insert the following:

SEC. ___. DEFICIT-NEUTRAL RESERVE FUND TO PROMOTE BIOMEDICAL RESEARCH.

The Chairman of the Committee on the Budget of the Senate may revise the allocations of a committee or committees, aggregates, and other appropriate levels in this resolution for one or more bills, joint resolutions, amendments, amendments between the Houses, motions, or conference reports relating to Federal investments in precision medicine and biomedical research, which may include increasing funding to account for inflation, to support finding ways to prevent, treat, and cure diseases or conditions like Alzheimer's and other life-threatening or chronic illnesses, and to provide long-term cost savings to the Federal Government, by the amounts provided in such legislation for those purposes, provided that such legislation would not increase the deficit over either the period of the total of fiscal years 2016 through 2020 or the period of the total of fiscal years 2016 through 2025.